Literature DB >> 31744647

Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study.

Yu-Li Lin1, Hung-Hsiang Liou2, Chih-Hsien Wang3, Yu-Hsien Lai4, Chiu-Huang Kuo5, Shu-Yuan Chen6, Bang-Gee Hsu7.   

Abstract

BACKGROUND/
PURPOSE: Sarcopenia is prevalent in chronic hemodialysis patients. This prospective cohort study evaluated the impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in 126 chronic hemodialysis patients.
METHODS: Skeletal muscle mass, handgrip strength (HGS), gait speed, and blood parameters were assessed. Sarcopenia was evaluated using the criteria of the European Working Group on Sarcopenia in Older People and the Taiwanese criteria for Sarcopenia. Muscle quality was defined as HGS divided by mid-arm muscle circumference.
RESULTS: Prevalences of uremic sarcopenia were 8.7% and 13.5% according to Taiwanese and European criteria, respectively. Low HGS and gait speed were much more prevalent than low muscle mass. Within 3 years, 79 (62.7%) patients were hospitalized and 26 (20.6%) died. Low HGS and slow gait speed were associated with hospitalization and mortality, while sarcopenia was associated with mortality but not with hospitalization. Notably, in our patients without sarcopenia, close associations between increased hospitalization and mortality risk with low HGS and slow gait speed remained unchanged. In Cox proportional hazard analysis, muscle quality [hazard ratio (HR) = 0.42, 95% confidence interval (CI) = 0.19-0.93, p = 0.032] and serum creatinine (HR = 0.82, 95% CI = 0.71-0.95, p = 0.009) were independently associated with composite outcome of hospitalization or death.
CONCLUSION: Muscle functionality and quality can predict hospitalization and overall survival in chronic hemodialysis patients, better than muscle mass.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Gait speed; Handgrip strength; Hemodialysis; Muscle quality; Sarcopenia

Mesh:

Year:  2019        PMID: 31744647     DOI: 10.1016/j.jfma.2019.10.020

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  9 in total

Review 1.  Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.

Authors:  Yuhei Otobe; Connie M Rhee; Matthew Nguyen; Kamyar Kalantar-Zadeh; Joel D Kopple
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

2.  Association of the modified creatinine index with muscle strength and mortality in patients undergoing hemodialysis.

Authors:  Rongrong Tian; Liyang Chang; Dan Liu; Fenxia Luo; Ying Zhang; Linghong Cheng; Hongmei Zhang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 3.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.

Authors:  Xiaoyu Shu; Taiping Lin; Hui Wang; Yanli Zhao; Tingting Jiang; Xuchao Peng; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-05       Impact factor: 12.910

4.  Characterization of the gut microbiota in hemodialysis patients with sarcopenia.

Authors:  Qifan Zhou; Hailin Zhang; Lixia Yin; Guilian Li; Wenxue Liang; Guanjie Chen
Journal:  Int Urol Nephrol       Date:  2021-11-29       Impact factor: 2.266

Review 5.  Assessment of uremic sarcopenia in dialysis patients: An update.

Authors:  Yu-Li Lin; Bang-Gee Hsu
Journal:  Tzu Chi Med J       Date:  2021-07-16

6.  The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b.

Authors:  Bin Duan; Xinxi Wang
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

7.  Development of a risk prediction nomogram for sarcopenia in hemodialysis patients.

Authors:  Genlian Cai; Jinping Ying; Mengyan Pan; Xiabing Lang; Weiping Yu; Qinqin Zhang
Journal:  BMC Nephrol       Date:  2022-09-23       Impact factor: 2.585

Review 8.  Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis.

Authors:  Wannasit Wathanavasin; Athiphat Banjongjit; Yingyos Avihingsanon; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

Review 9.  Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review.

Authors:  Hanaa Noor; Joanne Reid; Adrian Slee
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-28       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.